Evidence map›Paper›PMID 42756056›Full record

ArticleFrontiers in pharmacology2026

Shiny binary modeling platform: a reproducibility-oriented software platform for structured binary modeling with integrated interpretation, validation support, model comparison, and archive export.

Haikun Du, Xiaozhe Huang, Tianxiang Liu, Arzuye Dolkun

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Haikun Du *School of Pharmacy, Xinjiang Medical University, Urumqi, China.
Xiaozhe Huang *School of Pharmacy, Xinjiang Medical University, Urumqi, China.
Tianxiang LiuSchool of Pharmacy, Xinjiang Medical University, Urumqi, China.
Arzuye DolkunSchool of Pharmacy, Xinjiang Medical University, Urumqi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Structured binary modeling is often implemented through scattered scripts and temporary files, leaving preprocessing recipes, benchmarks, deployed models, interpretation outputs, and archive materials difficult to trace. This limits practical reproducibility and later reuse. Results: We developed Shiny Binary Modeling Platform, an R/Shiny application that links data setup, preprocessing retention, candidate-model benchmarking, final model deployment, SHAP-based interpretation, external-validation support, model comparison, and archive export in one project workflow. In a demonstration using 6383 traditional Chinese medicine-derived compound records, a source-derived pure-toxic-source label, and 12 ADME/physicochemical descriptors, the platform evaluated 113 candidate model specifications under stratified 10-fold cross-validation. Majority-class downsampling was applied only within training folds; assessment folds retained the original imbalanced distribution. The descriptor set was used to exercise the software workflow and should not be interpreted as a comprehensive endpoint-specific toxicity-QSAR feature set. No independent external validation dataset was used, so reported performance represents internal cross-validation only. Stepglm [both]+RF-a two-stage specification using both-direction stepwise logistic-regression screening followed by random forest-served as the primary performance-summary model for ROC/PR reporting and structured export. With pure_toxic_label = 1 as the toxic/positive class, its merged out-of-fold PR-AUC was 0.2469; at threshold 0.5, toxic-class precision/PPV, recall/sensitivity, F1, and NPV were 0.2288, 0.4091, 0.2935, and 0.9509. Archived global and local SHAP outputs were re-audited separately: the global outputs shown in were traced to the retained Lasso + RF historical reference project, whereas the local waterfall output shown in was traced to the Stepglm [both]+RF primary performance-summary model. Conclusion: This is a software article rather than a final endpoint-specific prediction study. The current use case demonstrates integrated benchmarking, deployment, internal OOF reporting, audited SHAP-output handling, model comparison, and reproducible export. External-validation support and standalone prediction-app export are implemented capabilities, but the single-dataset demonstration does not support independent external-performance, deployment-readiness, or competitive toxicity-QSAR claims.

Indexed as

archive exportmodel comparisonreproducible workflowSHAPShinystructured binary modeling

Identifiers

PMID42756056
PMCPMC13582506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.